Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.8904 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.94332 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.06396 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.6722 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.41758 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.05206 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.15901 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.01938 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.79292 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.90677 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.97281 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.94376 | 66 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.97564 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.3245 | 70 |